Science Explorer Interactive view Map
Topic · Nephrology

Renal Diseases and Glomerulopathies

Renal Diseases and Glomerulopathies is a research topic within Nephrology. Science Explorer counts 37k research works in it since 1950. 13.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathophysiology, genetics, and clinical aspects of glomerular diseases, including nephrotic syndromes such as membranous nephropathy, focal segmental glomerulosclerosis, and IgA nephropathy. It covers topics such as podocyte biology, renal thrombotic microangiopathy, genetic kidney diseases, and the role of the kidney barrier function in disease development.

  • Glomerular Diseases
  • Nephrotic Syndrome
  • Podocyte Biology
  • Membranous Nephropathy
  • Focal Segmental Glomerulosclerosis
  • IgA Nephropathy
  • Renal Thrombotic Microangiopathy
  • Podocyte Depletion
  • Genetic Kidney Diseases
  • Kidney Barrier Function
Research works
37k
fractional, since 1950
In the world top 10%
4.9k
per year above
Top-10% rate
13.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+27%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Renal Diseases and Glomerulopathies research?

By volume, the United States and China publish the most (1.5k and 1.3k works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.5k works
  2. 2 China 1.3k works
  3. 3 Japan 448 works
  4. 4 India 419 works
  5. 5 Germany 273 works
  6. 6 United Kingdom 264 works
  7. 7 Italy 237 works
  8. 8 France 196 works
  9. 9 Spain 188 works
  10. 10 South Korea 132 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.9%China: 25.7%Japan: 9.0%India: 8.4%6 others listed: 25.9%31%largest
United States1,538 · 30.9%China1,281 · 25.7%Japan448 · 9.0%India419 · 8.4%6 others listed1,290 · 25.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Renal Diseases and Glomerulopathies research?

By volume in 2022–2025, Peking University publishes the most Renal Diseases and Glomerulopathies research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Mayo Clinic.

By volume, 2022–2025

  1. 1 Peking UniversityChina 30 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 27 works
  3. 3 Mayo ClinicUnited States 25 works
  4. 4 University of MichiganUnited States 23 works
  5. 5 Peking University First HospitalChina 22 works
  6. 6 Icahn School of Medicine at Mount SinaiUnited States 22 works
  7. 7 Post Graduate Institute of Medical Education and ResearchIndia 22 works
  8. 8 University of North Carolina at Chapel HillUnited States 22 works
  9. 9 All India Institute of Medical SciencesIndia 21 works
  10. 10 Sanjay Gandhi Post Graduate Institute of Medical SciencesIndia 21 works

Who are the leading researchers in Renal Diseases and Glomerulopathies?

The most-cited researchers publishing on Renal Diseases and Glomerulopathies include Giuseppe Remuzzi, Johan Ärnlöv and Alberto Ortíz.

  1. 1 Giuseppe Remuzzi Italy 8.1k citations
  2. 2 Johan Ärnlöv Sweden 6.6k citations
  3. 3 Alberto Ortíz Spain 5.9k citations
  4. 4 Hermann Brenner Germany 5.8k citations
  5. 5 Vivekanand Jha India 5.8k citations
  6. 6 Josef Coresh United States 5.3k citations
  7. 7 André Pascal Kengne South Africa 4.5k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

Where is Renal Diseases and Glomerulopathies research done?

The largest centres of Renal Diseases and Glomerulopathies research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Guangzhou (China). Among places with at least 20 works in it, it is an unusually large share of all research in Rochester, Leicester and Birmingham.

Largest cities, 2022–2025

  1. 1 Beijing China 206 works
  2. 2 Tokyo Japan 140 works
  3. 3 Shanghai China 104 works
  4. 4 Guangzhou China 100 works
  5. 5 Paris France 98 works
  6. 6 New York United States 95 works
  7. 7 Boston United States 78 works
  8. 8 London United Kingdom 75 works
  9. 9 Seoul South Korea 73 works
  10. 10 Hangzhou China 72 works

Where it is the local speciality

  1. RochesterUS · 26.8 works9.9×
  2. LeicesterGB · 29.3 works9.4×
  3. BirminghamUS · 21.9 works5.9×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Renal Diseases and Glomerulopathies than the world average.

See Renal Diseases and Glomerulopathies on the map

Where is the best place to study Renal Diseases and Glomerulopathies?

Among universities, judged by research, University of Leicester, Zhejiang Chinese Medical University and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 19.1%fractional works in this node (log) →share in the world top 10% →University of Leicester: 18, 20.3%Zhejiang Chinese Medical University: 17, 21.3%Icahn School of Medicine at Mount Sinai: 22, 19.7%Universität Hamburg: 17, 26.7%Chinese Academy of Medical Sciences & Peking Union Medical College: 27, 17.5%Juntendo University: 15, 19.8%Shanxi Medical University: 11, 27.7%Post Graduate Institute of Medical Education and Research: 22, 4.0%Carol Davila University of Medicine and Pharmacy: 15, 10.2%Harvard University: 19, 23.8%Universität HamburgZhejiang Chinese Med…University of Leices…Icahn School of Medi…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 University of LeicesterUnited Kingdom 69.920.3%11.8×18 +69.6%
2 Zhejiang Chinese Medical UniversityChina 60.221.3%10.1×17 -12.9%
3 Icahn School of Medicine at Mount SinaiUnited States 59.719.7%6.8×22 +50.6%
4 Universität HamburgGermany 59.426.7%4.6×17 +69.8%
5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 58.817.5%4.3×27 +145.4%
6 Juntendo UniversityJapan 58.019.8%14.7×15 -13.7%
7 Shanxi Medical UniversityChina 53.927.7%7.9×11 -31.8%
8 Post Graduate Institute of Medical Education and ResearchIndia 52.84.0%10.0×22 +88.3%
9 Carol Davila University of Medicine and PharmacyRomania 49.910.2%14.7×15 +1.3%
10 Harvard UniversityUnited States 49.823.8%2.3×19 +17.8%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Renal Diseases and Glomerulopathies research growing?

Output in 2018–2022 was 27% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Renal Diseases and Glomerulopathies.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.